GLUCOCARD
LIVE

Serial Number

79348263

Owner

ARKRAY, Inc.

Attorney

Michael T. Olsen

Filing Date

Apr 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GLUCOCARD Trademark

Serial Number: 79348263 • Registration: 7245065

GLUCOCARD is a trademark filed by ARKRAY, Inc. on April 22, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ARKRAY, Inc.

57, Nishi Aketa-cho, Higashi-kujo
Kyoto 601-8045 , JP

Entity Type: 03

Trademark Details

Filing Date

April 22, 2022

Registration Date

December 19, 2023

Published for Opposition

October 3, 2023

Goods & Services

Providing information via the Internet in the field of diabetes; remote monitoring of medical data for medical diagnosis and treatment; providing information relating to dietary and nutritional guidance; managed health care services, namely, management of blood glucose levels; managed health care services; providing health care information based on data of blood glucose levels; providing health care information

Downloadable computer software for data management, data collection and analysis, of patient healthcare data; downloadable computer software for measuring and analyzing of blood glucose levels; recorded computer software for data management, data collection and analysis of patient healthcare data; recorded computer software for use in measuring and analyzing of blood glucose levels; wearable computers in the nature of wearable activity trackers for the collection, analysis, management, and sharing of user health data; wearable computers in the nature of wearable activity trackers for the collection, analysis, management, and sharing of patient health data, not for medical use; downloadable image files containing information about blood glucose monitoring; telecommunication machines and apparatus for data management, namely, wireless transmitters and receivers for use in the collection and analysis of patient healthcare data; personal digital assistants for data management, namely, data collection and analysis of patient healthcare data; personal digital assistants for use in measuring and analyzing of blood glucose levels

Providing online non-downloadable computer software for on-line data management, data collection, and analysis of patient healthcare data; providing online non-downloadable computer software for use in on-line blood sample analysis for medical purposes; software as a service (SaaS) services featuring software for on-line data management, data collection, and analysis of patient healthcare data; software as a service (SaaS) services featuring software for use in on-line blood sample analysis for medical purposes; platform as a service (PaaS) featuring computer software platforms for on-line data management, data collection, and analysis of patient healthcare data; platform as a service (PaaS) featuring computer software platforms for use in on-line blood sample analysis for medical purposes; electronic data storage for medical and health records; scanning of images, namely, the conversion of electronic data and documents from physical to electronic media

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 5, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 28, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 28, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 4, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 13, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 30, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 19, 2023 GNFN
FINAL REFUSAL E-MAILED
May 19, 2023 GNFR
FINAL REFUSAL WRITTEN
May 19, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 6, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 6, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 30, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 25, 2022 REPR